Patient leaflets and SmPCs, drug interaction checker, official and paediatric dosages, pregnancy and breastfeeding guidance, and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official and paediatric dosages, pregnancy and breastfeeding guidance, and NHS pharmacy opening hours — all in one place.
Methocarbamol oral suspension contains the medicine methocarbamol which belongs to a group of medicines called muscle relaxants.
Methocarbamol oral suspension is used for the short-term treatment of pain and muscle spasm caused by injuries such as sprains and strains, within adults.
Do not take Methocarbamol oral suspension if you • Are allergic (hypersensitive) to methocarbamol, or have had any problems in the past with medicines containing methocarbamol
• Are allergic to any of the other ingredients of this medicine (listed in section 6)
• Have ever suffered any brain damage or coma
• Suffer from epilepsy or convulsions
• Suffer from muscle weakness (a disease called myasthenia gravis)
Warnings and precautions Tell your doctor or pharmacist before taking Methocarbamol oral suspension if you:
• are pregnant or thinking of becoming pregnant
• are breastfeeding
• have, or have had, any kidney or liver problems
• are having any medical investigations or tests as Methocarbamol oral suspension could interfere with the results. Tell your doctor that you are taking Methocarbamol oral suspension before you have the test.
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking methocarbamol oral suspension.
Children and adolescents This medicine is not intended for use in children due to a lack of data.
Other medicines and Methocarbamol oral suspension Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. This includes medicines you buy without a prescription, including herbal medicines. This is because Methocarbamol affects the way some other medicines work.
Also some medicines can affect the way methocarbamol works.
If you are taking any of the following medicines, you should tell your doctor or pharmacist as Methocarbamol oral suspension may interact with them:
• Barbiturates which can be taken for epilepsy or to help you sleep.
• Appetite suppressants to help you lose weight.
• Medicines for stomach upsets or sea-sickness (anti-cholinergics).
• Psychotropic drugs for the treatment of anxiety, depression or other mental illnesses.
• If you are due to have anaesthetic for any reason, tell your doctor or dentist that you are taking Methocarbamol oral suspension.
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking methocarbamol oral suspension.
Methocarbamol oral suspension with food, drink and alcohol Do not drink alcohol while you are taking Methocarbamol oral suspension. Take Methocarbamol oral suspension with a glass of water.
Pregnancy, Breast-feeding and fertility Do not take this medicine if you are pregnant or might become pregnant unless your doctor tells you to.
Contact your doctor if you think you may be pregnant or are intending to become pregnant.
Do not take Methocarbamol oral suspension if you are breast-feeding or planning to breast-feed.
No data are available concerning the effect of this medicine on human fertility.
Driving and using machines Methocarbamol oral suspension may make you feel sleepy and may affect your ability to drive, operate machinery and carry out other hazardous activities. These activities should therefore be avoided altogether until you are sure you are not affected.
Sodium content This medicine contains less than 1 mmol sodium (23 mg) per 5ml, that is to say essentially ‘sodium-free’.
Sodium benzoate content This medicine contains 5mg sodium benzoate (E211) in each ml unit which is equivalent to 200mg total in the maximum daily dose.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Adults: Take 1500 mg Methocarbamol four times a day. Sometimes a lower dose may be sufficient. You should spread the doses as evenly as possible over a 24-hour period.
Elderly: older patients may only need half the usual dose to give the same relief from the pain and muscle spasms.
Children: The Methocarbamol oral suspension should not be given to children.
Liver impairment: you may need a longer interval between taking the suspension if you have liver disease.
You should always follow your doctor’s instructions carefully.
The Methocarbamol oral suspension is for short-term treatment. Take it for as long as your doctor has recommended, or until you no longer need it to ease the pain. Any unused medicine should be returned to your pharmacist.
Take Methocarbamol oral suspension with a glass of water.
Measuring your dose Instructions for use
The oral suspension must be shaken well before use.
• Open the bottle: press the cap and turn it anticlockwise (Figure 1).
• Insert the syringe adaptor into the bottle neck (Figure 2).
• Take the syringe and put it in the adaptor opening (Figure 3).
• Turn the bottle upside down (Figure 4).
• Fill the syringe with a small amount of solution by pulling the piston down (Figure 4A).Then push the piston upward in order to remove any possible bubbles (Figure 4B). Finally, pull the piston down to the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (Figure 4C).
• Turn the bottle the right way up (Figure 5A).
• Remove the syringe from the adaptor (Figure 5B).
• Put the end of the syringe into your mouth and push the piston slowly back in to take the medicine.
• Wash the syringe with water and let it dry before you use it again (Figure 6).
• Close the bottle with the plastic screw cap - leave the syringe adaptor in the bottle.
Cleaning and storing the syringe: 1. Wash the syringe with water and let it dry before you use it again/after each dose. Instructions for how to wash the syringe: pull the plunger out of the syringe and wash both parts in warm soapy water. Then rinse with water (see figure 6 above).
2. Dry the two parts. Push the plunger back into the syringe. Keep it in a clean safe place with the medicine.
If you take more Methocarbamol oral suspension than you should It is important to stick to your prescribed dose. If you or someone else takes too much medicine, contact your doctor or nearest hospital emergency department immediately. Always take any medicine left over with you and also the bottle of Methocarbamol oral suspension, as this will allow easier identification of the medicine.
If you forget to take Methocarbamol oral suspension If you forget to take a dose, simply take the next dose when it is due. Always leave at least 4 hours before taking any more dose of the methocarbamol oral suspension. DO NOT TAKE A DOUBLE DOSE OF SUSPENSIONTO MAKE UP FOR A MISSED DOSE.
If you stop taking Methocarbamol oral suspension Keep taking methocarbamol oral suspension until your doctor tells you to stop.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking your suspension and tell your doctor immediately if you experience any of the following rare symptoms:
• Confusion, convulsions, fits, and rash or swelling of the face or neck and shortness of breath which may be a sign of an allergy.
If you notice any of these symptoms, you should contact your doctor:
• Yellowing of the skin and/or whites of the eyes.
The levels of your white blood cells may also be reduced which can lead to recurrent:
• Infections,
• Mouth ulcers.
If any of the following side effects are troublesome, you should tell your doctor:
• Drowsiness, difficulty in sleeping,
• Restlessness, anxiety or worry,
• Dizziness,
• Memory loss,
• Blurred or double vision, rapid or unusual eye movements,
• Reddening of the eyes together with nasal stuffiness,
• Feeling sick or vomiting,
• Heartburn,
• Taste disturbance,
• Tremor or shakiness, mild muscle incoordination,
• Headache,
• Fever,
• Itching,
• A slow heartbeat,
• Flushing,
• Fainting or feeling faint,
• Low blood pressure.
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side affects you can also provide more information on the safety of this medicine.
• Keep this medicine out of the sight and reach of children.
• Do not use Methocarbamol oral suspension after the expiry date which is stated on the label of the container after “EXP”. The expiry refers to the last day of the month.
• Use within 30 days of opening the bottle.
• Do not throw away any medicines via waste water or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
What Methocarbamol oral suspension contains Methocarbamol oral suspension
• Each ml of oral suspension contains 150 mg Methocarbamol.
The other ingredients are:
• Sodium Benzoate (E211), Glycerine, Magnesium Aluminium silicate, Cellulose gum, Citric acid monohydrate, Tri-Sodium citrate dihydrate, Sucralose, Tutti-Frutti flavour and Purified water.
What Methocarbamol oral suspension looks like and contents of the pack Methocarbamol 750mg/5ml oral suspension is a ‘white to off white suspension’.
Methocarbamol 750mg/5ml oral suspension packaged in 180 ml type III Amber glass bottle with PP 28mm white CR closure lined with TE EPE
The package also contains a 10ml oral syringe with markings at 1ml and 0.25 ml intervals, along with an adapter.
Marketing authorisation holders Rosemont Pharmaceuticals Ltd
Yorkdale Industrial Park
Braithwaite Street
Leeds
LS11 9XE
UK
Tel: + 44 (0) 113 244 1400 Manufacturer LM Manufacturing Limited
Sandretto Building
Cavalry Hill Industrial Park
Weedon
Northampton
NN7 4PP
United Kingdom
Other sources of information
If you would like the leaflet in an alternative format information (braille or large print), for blind and partially sighted patients, please contact marketing authorisation holder listed above.
This leaflet was last revised in January 2026.
P3HD1RBJ1
V7
PLFT0350-0-348
CUG-PL-003
Rosemont Pharmaceuticals Limited
Address
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone
+44 (0)113 244 1400
Fax
+44 (0)113 245 3567
WWW
http://www.rosemontpharma.com
Customer Care direct line
+44 (0)800 919 312
Out of Hours contact
[email protected]
Out of Hours Telephone
+44 (0)795 762 3515
• Contact us
• Links
• Accessibility
• Legal and privacy notice
• Cookie notice
• Cookie Settings
• Glossary
• Site Maps
Delivered to you by
Methocarbamol 750mg/5ml Oral suspension comes as suspension containing 750mg/5ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Methocarbamol 750mg/5ml Oral suspension is methocarbamol.
Medicines with the same active substance include: Methocarbamol 1500 mg film coated-Tablet, Methocarbamol 1500 mg film-coated tablets, Methocarbamol 1500 mg tablets, Methocarbamol 750 mg film coated-Tablet, Methocarbamol 750 mg film-coated tablets, Methocarbamol 750 mg tablets. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Methocarbamol 750mg/5ml Oral suspension, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
As a short-term adjunct to the symptomatic treatment of acute musculoskeletal disorders associated with painful muscle spasms. Methocarbamol is indicated in adults.
For oral use.
Posology
Adults
The usual dose is 1500 mg (10ml) four times daily, but therapeutic response has been achieved with doses as low as 750 mg (5ml) three times daily.
Elderly
Half the maximum dose or less may be sufficient to produce a therapeutic response.
Paediatric population
The safety and efficacy of Methocarbamol in children and adolescent has not yet been established, therefore no data are available. Methocarbamol should not be used in children.
Hepatically impaired
In patients with chronic hepatic disease the elimination half-life may be prolonged. Therefore, consideration should be given to increasing the dose interval.
Duration of Treatment:
The duration of administration depends on the symptoms induced by increased muscle tone, but should not exceed 30 days.
Method of Administration
For oral use.
Shake well before use.
Take Methocarbamol oral suspension with a glass of water.
- Hypersensitivity to methocarbamol or to any of the excipients listed in section 6.1.
- Coma or pre-coma states.
- Known brain damage or epilepsy.
- Myasthenia gravis.
This product may potentiate the effects of other central nervous system depressants and stimulants including alcohol, barbiturates, anaesthetics and appetite suppressants. The effects of anticholinergics, e.g. atropine and some psychotropic drugs, may be potentiated by methocarbamol. Methocarbamol may inhibit the effect of pyridostigmine bromide. Therefore, methocarbamol should be used with caution in patients with myasthenia gravis receiving anticholinesterase agents. Little is known about the possibility of interactions with other drugs.
Methocarbamol may cause colour interference in certain screening tests for 5-hydroxyindolacetic acid (5-HIAA) using nitrosoaphthol reagent and in screening tests for urinary vanillymandelic acid (VMA) using the Gitlow method.
Fertility
Animal reproductive studies have not been conducted with methocarbamol.
Pregnancy
It is also not known whether methocarbamol can cause foetal harm when administered to a pregnant woman or can affect reproduction capacity.
Safe use of methocarbamol has not been established with regard to possible adverse effects upon foetal development. There have been very rare reports of foetal and congenital abnormalities following in utero exposure to methocarbamol. Therefore methocarbamol should not be used in women who are or may become pregnant and particularly during early pregnancy unless in the judgement of the physician the potential benefits outweigh the possible hazards.
Breast-feeding
Methocarbamol and/or its metabolites are excreted in the milk of dogs: however, it is not known whether methocarbamol or its metabolites are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Methocarbamol is administered to a nursing woman.
Methocarbamol has moderate influence on the ability to drive and use machines as methocarbamol may cause dizziness or drowsiness- especially if other medications capable of causing drowsiness are also being taken. Patients should be cautioned that if dizziness or drowsiness are experienced these activities have to be avoided.
Limited information is available on the acute toxicity of methocarbamol. Overdose of methocarbamol is frequently in conjunction with alcohol or other CNS depressants and includes the following symptoms: nausea, drowsiness, blurred vision, hypotension, seizures and coma. One adult survived the deliberate ingestion of 22 to 30 grams of Methocarbamol without serious toxicity. Another adult survived a dose of 30 to 50 grams. The principal symptom in both cases was extreme drowsiness. Treatment was symptomatic and recovery was uneventful. However, there have been cases of fatal overdose.
Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of haemodialysis in managing overdose is unknown.
Ask anything about Methocarbamol 750mg/5ml Oral suspension. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.